Bladder wash could cut infections and hospital visits for catheter users

NCT ID NCT06163469

Recruiting now Disease control Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a bladder wash with a low-dose antiseptic (chlorhexidine) during routine catheter changes can reduce urinary tract infections and unplanned healthcare visits. Seventy adults with a long-term suprapubic catheter and a history of UTIs will receive the wash every three months for nine months. The goal is to see if the procedure is comfortable and practical in an outpatient setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: chlorhexidine gluconate bladder instillation
What this could lead to: If it works, this could offer a simple, in-office procedure to reduce urinary tract infections and unplanned hospital visits for people with neurogenic bladder.
What could go wrong: This is a small, early feasibility study with only 70 participants. The treatment may not reduce infections or may cause discomfort. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROGENIC BLADDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Urinary Bladder, Neurogenic Urinary Retention urinary tract infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROGENIC BLADDER URINARY RETENTION

Contacts and locations

Locations

Yale New Haven Health
RECRUITING

New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.